QRG Capital Management Inc. trimmed its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) by 47.7% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 34,616 shares of the real estate investment trust’s stock after selling 31,596 shares during the period. QRG Capital Management Inc.’s holdings in Sabra Healthcare REIT were worth $645,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its position in shares of Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the period. Farther Finance Advisors LLC raised its holdings in Sabra Healthcare REIT by 685.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 3,952 shares of the real estate investment trust’s stock worth $74,000 after acquiring an additional 3,449 shares during the period. Ameritas Advisory Services LLC acquired a new position in Sabra Healthcare REIT during the 2nd quarter worth $84,000. Hilltop National Bank bought a new stake in Sabra Healthcare REIT during the second quarter valued at about $96,000. Finally, Allworth Financial LP grew its position in shares of Sabra Healthcare REIT by 105.9% in the second quarter. Allworth Financial LP now owns 5,213 shares of the real estate investment trust’s stock valued at $96,000 after purchasing an additional 2,681 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.
Analyst Ratings Changes
A number of equities analysts have recently commented on the company. Wells Fargo & Company lifted their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Truist Financial raised their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a report on Tuesday. National Bankshares set a $22.00 price target on Sabra Healthcare REIT in a report on Friday, October 17th. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Saturday, January 3rd. Finally, Cantor Fitzgerald initiated coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $21.11.
Sabra Healthcare REIT Price Performance
Shares of SBRA stock opened at $19.31 on Thursday. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $19.97. The company has a market capitalization of $4.81 billion, a P/E ratio of 26.82, a P/E/G ratio of 1.17 and a beta of 0.67. The stock has a 50 day moving average of $19.04 and a two-hundred day moving average of $18.69. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. The business had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.Sabra Healthcare REIT’s quarterly revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. As a group, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Stockholders of record on Monday, November 17th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.2%. The ex-dividend date of this dividend was Monday, November 17th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 166.67%.
Sabra Healthcare REIT Profile
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.
Further Reading
- Five stocks we like better than Sabra Healthcare REIT
- Wall Street Alert: Buy AES
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The AI Boom Is Creating a New Kind of Infrastructure Opportunity
- Trump’s Hand-Written Letter Will Shock his Haters
- Bitcoin is down but your income is about to explode
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
